Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
ConclusionAxillary evaluation was recommended in patients with larger tumor size (>2 cm), multifocal lesions or ER+HER2+ status. Despite of a 51.98% upstaging rate, the rate of axillary metastasis in these patients was relatively low, supporting the omission of axillary evaluation in selected patients with low risk of upstaging or axillary metastasis.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Jing Si,
Rong Guo,
Naisi Huang,
Bingqiu Xiu,
Qi Zhang,
Weiru Chi,
Jiong Wu Tags: ORIGINAL RESEARCH Source Type: research
More News: Breast Cancer | Breast Carcinoma | Breast Needle Aspiration | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | HER2 | Pathology | Study